Ning Gu

22PUBLICATIONS
15CO-AUTHORS
GlycoconjugatesTraditional Chinese medicine and treatmentsMedical infection agents (incl. prions)Epidemiological modellingPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Apr 20, 2026
Coffee Consumption and Risk of Diabetic Angiopathy: Mediating Role of Gut Microbiota Revealed by Mendelian Randomization.

|Dec 26, 2023
Guanxin V alleviates ventricular remodeling after acute myocardial infarction with circadian disruption by regulating mitochondrial dynamics.

Songyi Cheng, Jing Wu, Yinghao Pei

|Aug 25, 2023
lnc-MRGPRF-6:1 Promotes ox-LDL-Induced Macrophage Ferroptosis via Suppressing GPX4.

Zhihuan You, Xiaotian Ye, Meihua Jiang

|Sep 23, 2022
Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247-1251.

Bo Liang, Ning Gu

|Aug 15, 2022
Empagliflozin for Patients with Heart Failure and Type 2 Diabetes Mellitus: Clinical Evidence in Comparison with Other Sodium-Glucose Co-transporter-2 Inhibitors and Potential Mechanism.

Bo Liang, Rui Li, Peng Zhang

|Jun 10, 2022
Pharmacological mechanisms of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction.

Bo Liang, Yi Liang, Ning Gu

Pageof 4

Frequent Collaborators

16 joint publications

Bo Liang

3 joint publications

Yu-Xiu Zhao

1 joint publications

Xin He

1 joint publications

Hui-Zhi Gong